{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:36:21Z","timestamp":1790750181382,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11060-020-03525-5","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T06:02:56Z","timestamp":1589349776000},"page":"343-352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Use of FDG-PET\/CT for systemic assessment of suspected primary central nervous system lymphoma: a LOC study"],"prefix":"10.1007","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9954-8866","authenticated-orcid":false,"given":"Marc","family":"Bertaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Houillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Edeline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Odile","family":"Habert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Mokhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Giron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Bergeret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khe","family":"Hoang-Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Cassoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Touitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Choquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Soussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Kas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"issue":"2","key":"3525_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00234-012-1089-6","volume":"55","author":"K Yamashita","year":"2013","unstructured":"Yamashita K, Yoshiura T, Hiwatashi A, Togao O, Yoshimoto K, Suzuki SO et al (2013) Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and 18F-fluorodeoxyglucose positron emission tomography. Neuroradiology 55(2):135\u2013143","journal-title":"Neuroradiology"},{"key":"3525_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/247152","volume":"2013","author":"N Kawai","year":"2013","unstructured":"Kawai N, Miyake K, Yamamoto Y, Nishiyama Y, Tamiya T (2013) 18F-FDG PET in the diagnosis and treatment of primary central nervous system lymphoma. BioMed Res Int 2013:1\u20138","journal-title":"BioMed Res Int"},{"issue":"11","key":"3525_CR3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/MNM.0b013e328264ae7f","volume":"28","author":"D Karantanis","year":"2007","unstructured":"Karantanis D, O\u2019Neill BP, Subramaniam RM, Witte RJ, Mullan BP, Nathan MA et al (2007) 18F-FDG PET\/CT in primary central nervous system lymphoma in HIV-negative patients. Nucl Med Commun 28(11):834\u2013841","journal-title":"Nucl Med Commun"},{"issue":"3","key":"3525_CR4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s11060-017-2686-3","volume":"136","author":"D Albano","year":"2018","unstructured":"Albano D, Bosio G, Bertoli M, Giubbini R, Bertagna F (2018) 18F-FDG PET\/CT in primary brain lymphoma. J Neurooncol 136(3):577\u2013583","journal-title":"J Neurooncol"},{"issue":"7","key":"3525_CR5","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1016\/S1470-2045(15)00076-5","volume":"16","author":"K Hoang-Xuan","year":"2015","unstructured":"Hoang-Xuan K, Bessell E, Bromberg J, Hottinger AF, Preusser M, Rud\u00e0 R et al (2015) Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol 16(7):e322\u2013e332","journal-title":"Lancet Oncol"},{"key":"3525_CR6","doi-asserted-by":"crossref","unstructured":"Vitolo U, Seymour JF, Martelli M, Illerhaus G, Illidge T, Zucca E, et al. 2016. Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. Jul 4; mdw175.","DOI":"10.1093\/annonc\/mdw175"},{"key":"3525_CR7","unstructured":"NCCN Guidelines, Retrieved from https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cns.pdf"},{"issue":"9","key":"3525_CR8","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3324\/haematol.2015.126110","volume":"100","author":"G Damaj","year":"2015","unstructured":"Damaj G, Ivanoff S, Coso D, Ysaebert L, Choquet S, Houillier C et al (2015) Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case retrospective study from LYSA and the LOC network. Haematologica 100(9):1199\u20131206","journal-title":"Haematologica"},{"issue":"22","key":"3525_CR9","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1200\/JCO.2005.13.524","volume":"23","author":"LE Abrey","year":"2005","unstructured":"Abrey LE (2005) Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23(22):5034\u20135043","journal-title":"J Clin Oncol"},{"issue":"5","key":"3525_CR10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/(SICI)1097-0142(19960301)77:5<827::AID-CNCR4>3.0.CO;2-B","volume":"77","author":"AJ Ferreri","year":"1996","unstructured":"Ferreri AJ, Reni M, Zoldan MC, Terreni MR, Villa E (1996) Importance of complete staging in non-Hodgkin\u2019s lymphoma presenting as a cerebral mass lesion. Cancer 77(5):827\u2013833","journal-title":"Cancer"},{"issue":"1","key":"3525_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF01054724","volume":"25","author":"BP O\u2019Neill","year":"1995","unstructured":"O\u2019Neill BP, Dinapoli RP, Kurtin PJ, Habermann TM (1995) Occult systemic non-Hodgkin\u2019s lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough? J Neurooncol 25(1):67\u201377","journal-title":"J Neurooncol"},{"issue":"2","key":"3525_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1215\/15228517-2007-061","volume":"10","author":"NA Mohile","year":"2008","unstructured":"Mohile NA, DeAngelis LM, Abrey LE (2008) The utility of body FDG PET in staging primary central nervous system lymphoma. Neuro-Oncol 10(2):223\u2013228","journal-title":"Neuro-Oncol"},{"issue":"2","key":"3525_CR13","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1148\/radiol.2019190133","volume":"292","author":"CH Suh","year":"2019","unstructured":"Suh CH, Kim HS, Park JE, Jung SC, Choi CG, Kim SJ (2019) Primary central nervous system lymphoma: diagnostic yield of whole-body CT and FDG PET\/CT for initial systemic imaging. Radiology 292(2):440\u2013446","journal-title":"Radiology"},{"issue":"4","key":"3525_CR14","doi-asserted-by":"publisher","first-page":"CNS46","DOI":"10.2217\/cns-2019-0016","volume":"8","author":"M Gupta","year":"2019","unstructured":"Gupta M, Gupta T, Purandare N, Rangarajan V, Puranik A, Moiyadi A et al (2019) Utility of fluoro-deoxy-glucose positron emission tomography\/computed tomography in the diagnostic and staging evaluation of patients with primary CNS lymphoma. CNS Oncol 8(4):CNS46","journal-title":"CNS Oncol"},{"key":"3525_CR15","first-page":"1","volume":"10","author":"R Malani","year":"2019","unstructured":"Malani R, Bhatia A, Wolfe J, Grommes C (2019) Staging identifies non-CNS malignancies in a large cohort with newly diagnosed lymphomatous brain lesions. Leuk Lymphoma 10:1\u20135","journal-title":"Leuk Lymphoma"},{"issue":"27","key":"3525_CR16","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol Off J Am Soc Clin Oncol 32(27):3059\u20133068","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"3","key":"3525_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/bjh.12938","volume":"166","author":"C-C Wang","year":"2014","unstructured":"Wang C-C, Carnevale J, Rubenstein JL (2014) Progress in central nervous system lymphomas. Br J Haematol 166(3):311\u2013325","journal-title":"Br J Haematol"},{"issue":"3","key":"3525_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0303-8467(89)90119-4","volume":"91","author":"P Pohl","year":"1989","unstructured":"Pohl P, Oberhuber G, Dietze O, Vogl G, Pallua AK, Plangger CA et al (1989) Steroid-induced complete remission in a case of primary cerebral non-Hodgkin\u2019s lymphoma. Clin Neurol Neurosurg 91(3):247\u2013250","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"3525_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1023\/A:1005733416571","volume":"32","author":"B Pirotte","year":"1997","unstructured":"Pirotte B, Levivier M, Goldman S, Brucher JM, Brotchi J, Hildebrand J (1997) Glucocorticoid-induced long-term remission in primary cerebral lymphoma: case report and review of the literature. J Neurooncol 32(1):63\u201369","journal-title":"J Neurooncol"},{"issue":"25","key":"3525_CR20","doi-asserted-by":"publisher","first-page":"41518","DOI":"10.18632\/oncotarget.17456","volume":"8","author":"Y Zou","year":"2017","unstructured":"Zou Y, Tong J, Leng H, Jiang J, Pan M, Chen Z (2017) Diagnostic value of using 18F-FDG PET and PET\/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis. Oncotarget 8(25):41518","journal-title":"Oncotarget"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03525-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-020-03525-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03525-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:08:26Z","timestamp":1620864506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-020-03525-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["3525"],"URL":"https:\/\/doi.org\/10.1007\/s11060-020-03525-5","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"assertion":[{"value":"2 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}